DNA characterization services for CCG, CRS/eomi, cptac and dceg period of performance: 08/31/2019 - 08/30/2020
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
The Broad Institute, Inc. UEI H5G9NWEFHXN4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,220,717
Award facts
- Opportunity
-
- Solicitation for NCI Genomic Characterization Centers Pre-Solicitation · N02CO8700194 · Posted Nov 5, 2018
- Contract value 100% obligated
- $19,220,716.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$350,155 | |
| Other Administrative Action | -$129,735 | |
| Other Administrative Action | -$4,427,774 | |
| Exercise an Option | $853,455 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $5,601,175 | |
| Other Administrative Action | $124,026 | |
| Exercise an Option | $1,998,041 | |
| Exercise an Option | $2,554,462 | |
| Other Administrative Action | -$13,087 | |
| Exercise an Option | $3,824,300 | |
| Other Administrative Action | $0 | |
| Original award | $9,186,008 |
Show all 13
About this award
The National Cancer Institute issued a delivery order to The Broad Institute, Inc. on August 31, 2019, under the NCI Genomic Characterization Centers parent vehicle with a ceiling value of $19.2 million for DNA characterization services supporting the Cancer Genome Characterization Centers, Cancer Research Services/Extramural Operations and Management Integration, Clinical Proteomic Tumor Analysis Consortium, and Division of Cancer Epidemiology and Genetics.
The initial period of performance ran from August 31, 2019 through August 30, 2020. Place of performance is Cambridge, MA. The order is priced on a firm fixed-price basis with no set-aside.
Service Contract Inventory reporting shows the order generated $1.9 million in invoiced revenue in FY2020, growing to $6.3 million in FY2021 (0.8 FTEs, 1,660 contractor hours at $3,790.88/hr), then moderating to $6.2 million in FY2024 (0.8 FTEs, 1,560 contractor hours at $3,953.26/hr). Derived hourly rates remained stable across fiscal years 2021–2024. The Broad self-performed all reported hours with no subcontractors recorded in SCI data.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to The Broad Institute, Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $19,220,717 on 75N91019F00129.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under 75N91019D00029, an indefinite delivery contract, on NCI Genomic Characterization Centers.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award